Company to hold conference call at 8:30 AM ET today CAMBRIDGE, Mass. , Nov. 12, 2019 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) today provided a clinical update on SGT-001 and reported that the U.S. Food and Drug Administration ( FDA ) has notified the company that IGNITE DMD, its